Author Question: The question, Is a criterion-referenced measurement tool a valid and reliable indicator of clinical ... (Read 29 times)

JGIBBSON

  • Hero Member
  • *****
  • Posts: 538
The question, Is a criterion-referenced measurement tool a valid and reliable indicator of clinical nursing competence? would most likely appear in which of the following sections of a research report?
 
  A) introduction
  B) methods
  C) results
  D) conclusion

Question 2

Between-group variation in ANOVA involves differences between _______ to the ________. (Fill in the blanks.)
 
  a. Individual scores, group means
  b. Individual scores, grand mean
  c. Means of one group, means of another group
  d. Group means, grand mean



Kimmy

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

A

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library